Ideaya Biosciences, Inc. · NASDAQ:IDYA
Hata Yujiro S sold 26,338 Ideaya Biosciences, Inc. shares (Form 4)
Traded Oct 6, 2026 · Filed Oct 8, 2026
On Oct 6, 2026, Hata Yujiro S (Director, President and CEO) sold 26,338 Ideaya Biosciences, Inc. shares at an average US$37.41 for US$985K under a trading plan, leaving 690,695 shares. Filed Oct 8, 2026 (Form 4).
- Sold
- 26,338 shares
- Price
- US$37.41 average (US$37.39 to US$38.26)
- Value
- US$985K
- Holding after
- 690,695 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Common Stock | Option exercise | 26,338 | US$4.31 | 717,033 | Direct |
| Oct 6, 2026 | Common Stock | Sale | 25,538 | US$37.39 | 691,495 | Direct |
| Oct 6, 2026 | Common Stock | Sale | 800 | US$38.26 | 690,695 | Direct |
Source
Related
- Ideaya Biosciences, Inc.
- Hata Yujiro S
- Ideaya Biosciences, Inc. shareholders
- Schedule 13G · Baker Bros. Advisors LP · Aug 14, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Ruiz Briseno Andres · Jul 9, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026